Network


Latest external collaboration on country level. Dive into details by clicking on the dots.

Hotspot


Dive into the research topics where Tuncer Haznedaroglu is active.

Publication


Featured researches published by Tuncer Haznedaroglu.


Parasitology International | 2008

Molecular epidemiology of Blastocystis infections in Turkey.

Mustafa Özyurt; Özgür Kurt; Kåre Mølbak; Henrik Vedel Nielsen; Tuncer Haznedaroglu; Christen Rune Stensvold

Blastocystis is a very common unicellular intestinal parasite of ubiquitous occurrence. In order to describe the molecular epidemiology of Blastocystis infections in Turkey, 87 isolates from 69 symptomatic and 18 asymptomatic individuals were sequenced. Sequence data were phylogenetically analyzed and statistically tested against unmodifiable risk factors such as gender and age. Blastocystis-positive males were complaining mainly of gastroenteritis, whereas dyspepsia was the chief complaint among Blastocystis-positive females. Blastocystis sp. subtypes detected in the study included subtypes 1, 2, 3 and 4, subtype 3 being the most predominant (75.9%). No association was detected between Blastocystis sp. subtype and symptoms (p>0.365), or between infection intensity and symptoms (p>0.441). There was a tendency of subtype 2 isolates being more common among older study individuals, and subtype 2 isolates were significantly associated with higher parasite abundance (p=0.017). Compared to data from similar studies, the distribution of Blastocystis sp. isolates in Turkey was found to more or less reflect the one seen in other countries, and it was deduced that subtype 3 is generally by far the most common subtype infecting humans, followed by subtypes 1, 2 and 4.


Otolaryngology-Head and Neck Surgery | 2009

Real-time PCR detection of Helicobacter pylori and virulence-associated cagA in nasal polyps and laryngeal disorders:

Mustafa Özyurt; Atila Gungor; Koray Ergunay; Engin Cekin; Evren Erkul; Tuncer Haznedaroglu

Objective: To identify Helicobacter pylori and major virulance factor, cagA, in patients with laryngeal diseases and nasal polyps. Study Design: Cross-sectional study with planned data collection. Setting: The study was performed on fresh tissue samples from patients with 32 nasal polyps, 29 normal nasal mucosa, and 27 laryngeal diseases presenting to the Otolaryngology–Head and Neck Surgery department of a major military hospital in Istanbul, Turkey. Subjects and Methods: Tissue specimens were evaluated by in-house polymerase chain reaction (PCR) and real-time PCR for bacterial DNA and by real-time PCR for cagA. The impact of commercial and in-house DNA extraction methods was also evaluated. Results: H pylori DNA was detected only by real-time PCR in 59.4 percent of nasal polyps, 70.4 percent of nasal mucosa samples, and 58.6 percent of larynx samples. cagA was identified in 78.9, 89.5, and 82.4 percent of positive polyp, nasal mucosa, and larynx samples, respectively. No statistically significant differences were observed between groups. DNA purification methods were equally effective. Conclusion: H pylori DNA is present in nasal polyp and larynx tissues as well as normal nasal mucosa, as detected by a sensitive real-time PCR assay. cagA-positive strains dominate in all groups.


Central European Journal of Medicine | 2008

Comparison of octenidine dihydrochloride (Octenisept®), polihexanide (Prontosan®) and povidon iodine (Betadine®) for topical antibacterial effects in Pseudomonas aeruginosa-contaminated, full-skin thickness burn wounds in rats

Fatih Uygur; Mustafa Özyurt; Rahmi Evinc; Tugrul Hosbul; Bahattin Çeliköz; Tuncer Haznedaroglu

Pseudomonas aeruginosa is one of the most frequently isolated organisms from infected burn wounds and a significant cause of nosocomial infection and septic mortality among burn patients. In this animal study, three antiseptic agents which were Octenidine dihydrochloride (Octenisept®, Schülke & Mayr, Norderstedt, Germany), polyhexanide (Prontosan®, B. Braun, Melsungen AG, Germany) and povidon iodine (Betadine, Purdue Pharma L.P, Stamford, USA) were compared to assess the antiseptic effect of their applications on experimental burn wounds in in rats contaiminated with P. aeruginosa. All treatment modalities were effective against P. aeruginosa because there were significant differences between treatment groups and control groups. The mean eschar concentrations were not different between polyhexanide and povidon iodine groups, but there were significant differences between the octenidine dihydrochloride group and the other treatment groups, indicating that the Octenidine dihydrochloride significantly eliminated P. aeruginosa more effectively in the tissues compared to the to other agents. All treatment modalities were sufficient to prevent the P. aeruginosa invasion into the muscle and to cause systemic infection. In conclusion, Octenidine dihydrochloride is the most effective antiseptic agent in the treatment of the P. aeruginosa-contaminated burn wounds; Octenidine dihydrochloride can be considered as a treatment choice because of its peculiar ability of limit the frequency of replacing wound dressings.


European Journal of Clinical Microbiology & Infectious Diseases | 1995

Development of resistance to imipenem among nosocomial isolates ofPseudomonas aeruginosa

Ahmet Celal Başustaoğlu; Hüseyin Gün; Mehmet Ali Saracli; Mehmet Baysallar; Tuncer Haznedaroglu

Irnipenem was supplied in powder form by Merck Sharp and Dohme (USA), and a stock solution was prepared in accordance with NCCLS recommendations (3). One hundred nosocomial Pseudornonas aeruginosa strains collected from different clinical sites during the first six months of 1992 and 1994 were obtained from bacteriology laboratories (Department of Microbiology, G~Ihone Military Medical Academy). The patients from whom the cultures obtained were evaluated according to the CDC criteria for nosocomial infection (4). The bacteria were subcultured on sheep blood agar (5-7 %), maintained on Tripticase agar slants and tested for antibiotic susceptibility using Mueller-Hinton broth (Gibco BRL, UK).


American Journal of Infection Control | 2015

Surgical site infection rates in 16 cities in Turkey: findings of the International Nosocomial Infection Control Consortium (INICC)

Hakan Leblebicioglu; Nurettin Erben; Victor D. Rosenthal; Alper Sener; Cengiz Uzun; Gunes Senol; Gulden Ersoz; Tuna Demirdal; Fazilet Duygu; Ayse Willke; Fatma Sirmatel; Nefise Oztoprak; Iftihar Koksal; Oral Oncul; Yunus Gurbuz; Ertugrul Guclu; Huseyin Turgut; Ata Nevzat Yalcin; Davut Ozdemir; Tanıl Kendirli; Turan Aslan; Saban Esen; Fatma Ulger; Ahmet Dilek; Hava Yilmaz; Mustafa Sunbul; Ilhan Ozgunes; Gaye Usluer; Metin Otkun; Ali Kaya

BACKGROUND Surgical site infections (SSIs) are a threat to patient safety; however, there were no available data on SSI rates stratified by surgical procedure (SP) in Turkey. METHODS Between January 2005 and December 2011, a cohort prospective surveillance study on SSIs was conducted by the International Nosocomial Infection Control Consortium (INICC) in 20 hospitals in 16 Turkish cities. Data from hospitalized patients were registered using the Centers for Disease Control and Prevention (CDC) National Healthcare Safety Network (NHSN) methods and definitions for SSIs. Surgical procedures (SPs) were classified into 22 types according to International Classification of Diseases, Ninth Revision criteria. RESULTS We recorded 1879 SSIs, associated with 41,563 SPs (4.3%; 95% confidence interval, 4.3-4.7). Among the results, the SSI rate per type of SP compared with rates reported by the INICC and CDC NHSN were 11.9% for ventricular shunt (vs 12.9% vs 5.6%); 5.3% for craniotomy (vs 4.4% vs 2.6%); 4.9% for coronary bypass with chest and donor incision (vs 4.5 vs 2.9); 3.5% for hip prosthesis (vs 2.6% vs 1.3%), and 3.0% for cesarean section (vs 0.7% vs 1.8%). CONCLUSIONS In most of the 22 types of SP analyzed, our SSI rates were higher than the CDC NHSN rates and similar to the INICC rates. This study advances the knowledge of SSI epidemiology in Turkey, allowing the implementation of targeted interventions.


Scandinavian Journal of Infectious Diseases | 1995

Short-term quinolones for successful eradication of multiply resistant vibrio cholerae in adult patients

Levent Doganci; Hüseyin Gün; Mehmet Baysallar; Ali Albay; Eşref Çinar; Tuncer Haznedaroglu

There has been an increasing multiple drug resistance problem in Vibrio cholerae biotype Eltor, the causative agent of 7th pandemic. The aim of this study was to show in vitro and in vivo susceptibility and effectiveness of quinolones in the treatment of endemic cholera cases. Excellent results were obtained in 53 bacteriologically confirmed cholera patients treated with short-term ofloxacin and ciprofloxacin. To our knowledge, there has been no previous report on this subject in the international medical literature. Our results show that quinolones can be an alternative drug for the treatment of multiply resistant V. cholerae infections.


Central European Journal of Medicine | 2010

Genitourinary tuberculosis in a 54-year-old woman: diagnostic difficulty

Harun Agca; Orhan Baylan; Mustafa Özyurt; Ali Acar; Uğur Demirpek; Tuncer Haznedaroglu

Genitourinary tuberculosis (GUTB) is an extrapulmonary manifestation of tuberculosis seen in 1.2% of all cases of tuberculosis. The clinical case of a 54-year-old woman diagnosed with GUTB is presented. Cloudy urine, abdominal pain, and microscopic hematuria led us to investigate for Mycobacterium tuberculosis. Although cultures were negative, positive Ehrlich-Ziehl-Neelsen (EZN) staining and a positive polymerase chain reaction (PCR) revealed the diagnosis of M. tuberculosis complex (MTC), which was confirmed by treatment success. It has been shown that PCR is a reliable and rapid method for establishing or supporting the diagnosis of tuberculosis and can be used in a routine diagnostic algorithm when conventional methods fail to identify MTC.


Open Medicine | 2008

Helicobacter pylori isolation, serology and cagA, cagE and virB11 detection in patients with non-ulcer dyspepsia from Turkey: Correlation with histopathologic findings

Ugur Ilga; Mustafa Özyurt; Sukru Yildirim; Koray Ergunay; Nurittin Ardic; Levent Demirturk; Tuncer Haznedaroglu

Colonization with Helicobacter pylori (HP) may have major clinical consequences and HP virulence factors are associated with more severe gastroduodenal pathologies. In this study, prevalence of HP in patients with Non-Ulcer Dyspepsia (NUD) was determined by rapid urease test and culture and correlations of histopathologic changes with bacterial virulence factors and serologic profiles were investigated. Gastric biopsies from sixty-nine patients admitted to Haydarpasa Training Hospital Department of Gastroenterology were evaluated for rapid urease, HP isolation and examined histopathologically. PCR was employed for HP confirmation and detection of HP cagA, cagE and virB11 genes. For each patient, IgG and IgA antibodies and anti-cagA antibodies were also determined by ELISA tests. HP was isolated and confirmed by PCR in 74% (51/69) of the patients. Anti-HP IgG and IgA were detected in 96% (49/51) and 53% (27/51), respectively. Anti-cagA were present in 51% (26/51). cagA, cagE and virB11 were positive in 56.8% (29/51), 60.7% (31/51) and 58.8% (30/51) of the patients, respectively. Statistically significant correlation was observed between cagA PCR and inflammation/activity scores. Detection of cagA by molecular assays can be an alternative test that can be employed for individual patient assessment.


Central European Journal of Medicine | 2008

Cross-resistance and associated resistance in Escherichia coli isolates from nosocomial urinary tract infections between 2004–2006 in a Turkish Hospital

Mustafa Özyurt; Oral Oncul; Süleyman Ceylan; Tuncer Haznedaroglu; Fatih Sahiner; Nurittin Ardic

In this study, antimicrobial resistance profiles were determined for 748 isolates of Escherichia coli from patients with acute nosocomial urinary tract infections (UTIs) at a Turkish Training Hospital. Thirteen antibiotics were included. Resistance to ampicillin alone (45.1%) and ciprofloxacin alone (20.6%) were the most commonly identified ‘single resistances’. Multiple resistance was found in 49.7% of the strains. The most common multiple antibiotic resistance profiles included ampicillin-sulbactam/amoxycilline-clavulonate (4.0%) and ampicillin-sulbactam/trimethoprim-sulfamethoxazole/amoxycilline-clavulonate (2.8%). From 2004 to 2006, ampicillin, trimethoprim-sulfamethoxazole and ciprofloxacin resistant strains increased to 76% from 57%, 53% from 43% and 55% from 41%, respectively. The percentage of extended-spectrum β-lactamase (ESBL) producing strains was 7.8% and imipenem resistance was seen in 5.2% of ESBL positive strains. We conclude that clinically important E.coli strains have now emerged with broader multidrug resistance. Periodical evaluation of laboratory results and clinical surveillance are crucially important for optimal antibiotic management of UTIs and infection control policies.


Microbiological Research | 2006

Investigation of aminoglycoside modifying enzyme genes in methicillin-resistant staphylococci.

Nurittin Ardic; B. Sareyyüpoğlu; Mustafa Özyurt; Tuncer Haznedaroglu; Ugur Ilga

Collaboration


Dive into the Tuncer Haznedaroglu's collaboration.

Top Co-Authors

Avatar
Top Co-Authors

Avatar

Nurittin Ardic

Military Medical Academy

View shared research outputs
Top Co-Authors

Avatar

Oral Oncul

Military Medical Academy

View shared research outputs
Top Co-Authors

Avatar

Orhan Baylan

Military Medical Academy

View shared research outputs
Top Co-Authors

Avatar

Ugur Ilga

Military Medical Academy

View shared research outputs
Top Co-Authors

Avatar
Top Co-Authors

Avatar
Top Co-Authors

Avatar

Hüseyin Gün

Military Medical Academy

View shared research outputs
Top Co-Authors

Avatar
Top Co-Authors

Avatar

Uğur Demirpek

Military Medical Academy

View shared research outputs
Researchain Logo
Decentralizing Knowledge